Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

Constellation Energy stock today: CEG slips in thin year-end trade as Calpine deal stays in focus

NEW YORK, December 29, 2025, 23:50 ET — Market closed

  • Constellation Energy shares closed down 0.6% at $358.33.
  • Utilities were modestly higher, while U.S. stocks ended lower in holiday-thinned trading.
  • Investors continue to track power-demand drivers and the company’s pending Calpine acquisition steps.

Constellation Energy Corp shares slipped 0.6% on Monday, ending at $358.33 as trading volumes thinned in the final week of the year.

The dip matters because Constellation has become a proxy for the U.S. power-demand boom tied to artificial intelligence data centers, which are pushing grid planners and regulators to focus on supply constraints and reliability.

That backdrop has kept power producers in the spotlight even on quiet sessions, with investors balancing long-term demand themes against near-term catalysts such as regulatory milestones and financing steps tied to big deals.

Constellation traded between $356.63 and $369.00 and finished below its $360.00 opening price.

Utilities broadly held up, with the Utilities Select Sector SPDR Fund edging up about 0.2%. Vistra and NRG were little changed, while Talen fell about 1%.

Wall Street’s main indexes ended lower as technology shares retreated from last week’s gains that pushed the S&P 500 to record highs, according to Reuters. Minutes from the Federal Reserve’s previous meeting and weekly jobless claims are due later this week in an otherwise light data calendar. 1

For Constellation, traders have stayed focused on the power-price outlook in key markets such as PJM Interconnection, which runs the grid across a 13-state Mid-Atlantic and Midwest region. Capacity prices — payments to generators for being available when the grid needs them — hit $333.44 per megawatt-day in PJM’s latest auction, Reuters reported earlier this month. 2

Another overhang is Constellation’s planned acquisition of Calpine, a deal that would expand its generation footprint beyond its nuclear-heavy base. Constellation said on Dec. 5 it reached a resolution with the U.S. Department of Justice and that the Federal Energy Regulatory Commission approved the deal subject to divestitures, Reuters reported. 3

Financing steps tied to the Calpine transaction remain in motion. Constellation Energy Generation said on Dec. 23 it extended the expiration of private exchange offers and related consent solicitations for certain Calpine notes, moving the deadline to Jan. 12, 2026. 4

Constellation has also moved to extend the operating lives of key nuclear assets. The U.S. nuclear regulator approved 20-year license renewals for the Clinton and Dresden plants, Reuters reported, and Constellation chief generation officer Bryan Hanson said, “These license extensions will allow Clinton and Dresden to stay online for another two decades.” 5

Before the next session, traders are likely to watch for any regulatory filings or divestiture updates tied to the Calpine deal, along with power-market signals that affect forward pricing and contract demand across PJM and other regions.

Market calendars estimate Constellation’s next earnings date in mid-February, though the company has not confirmed a publication date. 6

On the technical side, Monday’s low near $356.63 is the closest support level on traders’ screens, while the session high near $369.00 marks the first resistance point after the stock’s late-December range.

Stock Market Today

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

IREN stock heads into Monday after 5% rebound as Microsoft AI financing stays in focus

7 February 2026
IREN shares closed up 5.1% at $41.83 Friday after reporting a $155.4 million quarterly loss and $184.7 million in revenue. The company announced $3.6 billion in GPU financing for its Microsoft contract, with $2.8 billion in cash as of Jan. 31. Bitcoin mining revenue fell, while AI cloud services rose. Traders await bitcoin’s weekend move and Monday’s market reaction.
Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

Cadence Bank stock is stuck at $42.11 after Huntington deal — what CADE holders watch next week

7 February 2026
Cadence Bank shares have been delisted following Huntington Bancshares’ takeover, with each Cadence share converted into 2.475 Huntington shares. Huntington closed Friday at $19.27 and named Senthil Kumar as chief risk officer ahead of new regulatory requirements. The merger leaves Cadence as a brand under Huntington, with customer account conversions planned for mid-2026. Huntington executives will address investors at a UBS conference on Tuesday.
NIO stock jumps on profit alert, with Monday’s open in focus

NIO stock jumps on profit alert, with Monday’s open in focus

7 February 2026
NIO shares jumped 7.23% to $5.04 Friday after the company forecast a swing to adjusted operating profit of up to 1.2 billion yuan for the fourth quarter. Trading volume reached 90.8 million shares, far above average. Nio’s deliveries rose 72% to 124,807 vehicles in the quarter. The company said results are preliminary and unaudited, with final figures due in March.
Snap stock price bounces to $5.22 after upgrades — what traders watch next week

Snap stock price bounces to $5.22 after upgrades — what traders watch next week

7 February 2026
Snap Inc. shares closed up 2% at $5.22 Friday after a volatile week, with 94 million shares traded. The company forecast Q1 revenue below analyst expectations, despite a fourth-quarter beat and a 28% rise in active advertisers. Daily active users fell by 3 million to 474 million. Analysts remain divided, with some upgrading and others trimming price targets.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Previous Story

Stock Market Today 30.12.2025

Ultragenyx stock sinks 42% after Phase 3 setrusumab miss; what RARE investors watch nextNEW YORK, December 29, 2025, 23:21 ET — Market closed
Next Story

Ultragenyx stock sinks 42% after Phase 3 setrusumab miss; what RARE investors watch nextNEW YORK, December 29, 2025, 23:21 ET — Market closed

Go toTop